N
INMB icon

Nuveen’s INmune Bio INMB Stock Holding History

Nuveen’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.7K Hold
16,518
– – ﹤0.01% 3221
2025
Q4 		$25.8K Hold
16,518
– – ﹤0.01% 3244
2025
Q3 		$34.2K Hold
16,518
– – ﹤0.01% 3251
2025
Q2 		$38.2K Hold
16,518
– – ﹤0.01% 3270
2025
Q1 		$129K Hold
16,518
– – ﹤0.01% 3190
2024
Q4 		$77.1K Hold
16,518
– – ﹤0.01% 3303
2024
Q3 		$89K Hold
16,518
– – ﹤0.01% 3314
2024
Q2 		$146K Buy
+16,518
New +$163K ﹤0.01% 3273

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen's INMB Position: Q1 2026 in Review

Nuveen held its INmune Bio (INMB) position steady in Q1 2026 at 16,518 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3221.

Nuveen first reported a position in INMB in Q2 2024 and has held it in 8 quarters since. The position peaked at $146K in Q2 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Nuveen held 16,518 shares of INmune Bio worth $18.7K as of Q1 2026.
  • Nuveen left its INmune Bio share count unchanged in Q1 2026.
  • INmune Bio made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3221 holding.
  • Nuveen first reported a position in INmune Bio in Q2 2024 and has held it in 8 quarters since.
  • Nuveen's INmune Bio position peaked at $146K in Q2 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.